Reozalimab Antibody is a research-grade biosimilar monoclonal antibody targeting CD1. It is a human Ig(G1-kappa_G1-lambda2) antibody. Reactivity: Human. Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% purity as determined by SDS-PAGE. For research use only.
Reozalimab is a bispecific antibody targeting to PD-1/PD-L1. Reozalimab mediates antibody-dependent cell cytotoxicity in cancer research.
Product Name:
Reozalimab Antibody
SKU:
GXBS00795
Size:
100 µg, 1 mg
Antibody Type:
Monoclonal Antibody
Target:
B7 homolog 1
Isotype:
Ig(G1-kappa_G1-lambda2)
Host Species:
Human
Reactivity:
Human
Applications:
ELISA, FCM, Functional assay, Research in vivo
Synonyms:
Bispecific, IBI318, IBI-318, IBI318, 2445259-99-2
Purity:
>95% as determined by SDS-PAGE.
Endotoxin Level:
< 10 EU/mg
Formulation:
0.01M PBS pH 7.4.
State of Matter:
Liquid
Regulatory Status:
For research use only. Not suitable for clinical or therapeutic use.
Product Preparation:
Protein A/G purified from cell culture supernatant.
Storage and Handling:
Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
